Healthcare investment firm that finances medtech and biotech companies through equity and debt.
Profile being verified
What they look for
Granted Distalmotion a senior secured term loan facility of up to USD 70 M; Sam Chawla, portfolio manager, points to a focus on healthcare innovation. Participant in Vaderis Therapeutics' Series B.
Recent investments
Recorded Swiss rounds: Vaderis Therapeutics (Series B, USD 152 M, August 2026), Distalmotion (loan, amount not disclosed, October 2026, lead).
Rounds tracked by FundSwiss
- DistalmotionLoan · Amount not disclosed
- Vaderis TherapeuticsSeries B · USD 152 M